Clinical trial
The Effect of Dietary Glycocalyx Precursor Supplementation on Endothelial Function, on Markers of Vascular Function and on Cardiac Performance in Patients With COVID-19 Infection.
NCT05185934 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Dietary Glycocalyx Precursor Supplementation on Endothelial Function, on Markers of Vascular Function and on Cardiac Performance in Patients With COVID-19 Infection.
- Lead sponsor
- University of Athens
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- January 30, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, endothelial dysfunction